ANALYSIS OF DRUG UTILIZATION PATTERN IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL, SOUTH INDIA
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i4.49812Keywords:
Chronic kidney disease, Drug utilization pattern, Adverse drug reactionsAbstract
Objective: The objective of the study is to assess the drug utilization pattern of various drugs prescribed in chronic kidney disease (CKD) patients in a tertiary care hospital.
Methods: As a cross-sectional study 200 prescriptions were randomly selected from both the nephrology outpatient department and the inpatient ward. Patient demographics details, CKD staging, classes of drugs prescribed, and number of drugs prescribed were noted and data were analyzed with the World Health Organization core prescribing indicators.
Results: Incidence of CKD is more common in the age group of 40–50 years (45%) with male predominance (70%). Hypertension, diabetes, and anemia are the common comorbid conditions seen with CKD. Anti-hypertensives, anti-anemic drugs, calcium supplements, and anti-diabetic drugs are the commonly prescribed drugs in CKD. Number of prescription contains that generic names are near optimal and drugs from the National List of Essential Medicine are optimal. Majority of the prescriptions contain on average 5 drugs.
Conclusion: Diabetes and high blood pressure are the two most common causes of CKD with male dominance. Since polypharmacy is common in CKD patients , they should be monitored for drug – drug interaction and adverse drug reactions.
Downloads
References
World Health Organization. Introduction to Drug Utilization Research. Ch. 1. Geneva: World Health Organization; 2003. p. 8-12.
Carney EF. The impact of chronic kidney diseases on global health. Nat Rev Nephrol. 2020 May;16(5):251. doi: 10.1038/s41581-020-0268-7, PMID 32144399
Subeesh VK, Abraham R, Satya Sai MV, Koonisetty KS. Evaluation of prescribing practices and drug-related problems in chronic kidney disease patients: A cross-sectional study. Perspect Clin Res. 2020 Apr- Jun;11(2):70-4. doi: 10.4103/picr.PICR_110_18, PMID 32670831
Ansuman Abhisek P, Panda R, Samal R, Mohapatra N, Mohanty S. Drug utilisation pattern and adverse events in patients with chronic kidney disease undergoing maintenance haemodialysis at a tertiary care hospital of Odisha. J Clin Diagn Res. 2017 Oct;11(10):FC11-6.
Elhami E, Nagaraju K. Drug utilisation evaluation of antihypertensive drugs in diabetic patients with CKD. World J Pharm Pharm Sci. 2015;4(11):1159-66.
Boonson S, Vnnaprasaht S, Agoon Y. Therapeutic dosage ranges and chronic adverse effects of tacrolimus in Thai kidney transplant patients. Int J Appl Pharm. 2021;13(1):13-6.
Kanani NJ, Mistry VR, Rathva SJ. Drug utilization pattern in chronic kidney disease patients at a tertiary care teaching hospital. Innov Pharm Pharmacother. 2019;7(2):31-36.
Santra S, Agrawal D, Kumar S, Mishra SS. A study on the drug utilization pattern in patients with chronic kidney disease with emphasis on antibiotics. J Integr Nephrol Androl. 2015;2(3):85-9. doi: 10.4103/2225-1243.161435
Al-Ramahi R. Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia. Saudi J Kidney Dis Transpl. 2012;23(2):403-8. PMID 22382249
Ahlawat R, Cruz S, Tiwari P. Drug utilization pattern in chronic kidney disease patients at a tertiary care public teaching hospital: Evidence from a cross sectional study. J Pharm Care Health Syst. 2015;3:149.
Chakraborty S, Ghosh S, Banerjea A, De RR, Hazra A, Mandal SK. Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis. Indian J Pharmacol. 2016;48(5):586-90. doi: 10.4103/0253-7613.190760, PMID 27721548
Tozawa M, Iseki K, Iseki C, Oshiro S, Higashiuesato Y, Yamazato M, et al. Analysis of drug prescription in chronic haemodialysis Patients. Nephrol Dial Transplant. 2002;17(10):1819-24. doi: 10.1093/ ndt/17.10.1819, PMID 1227099113. Saju AP, Edakkarayil AC, Maheswari E, Gurudev KC. Prescribing pattern and cost effective analysis of antihypertensive drugs in chronic kidney disease patients. Eur J Pharm Med Res. 2016;3(1):219-25.
Tamilselvan T, Veerapandiyan AK, Karthik N. Study on drug utilization pattern of chronic renal failure patients in a tertiary care hospital. Hypertension. 2014;70:112.
Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyper phosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4(6):1089- 96. doi: 10.2215/CJN.00290109, PMID 19423571
Kappel J, Calissi P. Safe drug prescribing for patients with renal in sufficiency. CMAJ. 2002;166:473-7.
Atray P, Haque I, Bhyan SJ, Pathak K, Anjali. Evaluation of drug prescribing pattern in chronic kidney disease patients at tertiary care hospital in northern India -An observational study. World J Pharm Pharm Sci. 2021;10(2):1128-38.
Tamilselvan T, Veerapandiyan AK, Karthik N. Study on drug utilizationpattern of chronic renal failure patients in a tertiary care hospital. Int J Appl Pharm. 2014;6(9):482-484.
Shamkuwar CA, Kumari N, Meshram SH. Evaluation of prescribing pattern and survival of chronic kidney disease patients on haemodialysis: A perspective from super speciality tertiary care teaching hospital of central India. Indian J Appl Res. 2020;10(3):2249.
Thomas R, Sam S, Neelaphar P, Shabeeb P, Vishwanath BA. A study on prescribing pattern of antihypertensive in chronic kidney disease patients. J Drug Deliv Ther. 2020;10(3-S):75-81. doi: 10.22270/jddt. v10i3-s.4139
Rakshana S, Selva P. A study on prescription pattern among patients with chronic kidney diseases at tertiary care hospital. Curr Top Pharmacol. 2019;23: 51-58.
Roja Rani K, Yerramasetty SB, Munaswamy P. A cross sectional observational study on prescribing patterns of drugs in chronic kidney disease patients in a tertiary care teaching hospital. Acta Sci Pharm Sci. 2020 Nov;4(11):30-7.
Published
How to Cite
Issue
Section
Copyright (c) 2024 siyamala devi thamizharasan, Hemalatha K, Renuka A
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
